312 results
Page 3 of 16
8-K
EX-99.1
1m7a3ijc7
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
424B5
far842sxl2jqhfb7o1mx
29 Jul 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
fvlc3ld kjtfncwh8z
5 May 22
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
9:04am
8-K
EX-99.1
5pq3z0 7vvdai
28 Feb 22
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
12:00am
8-K
EX-99.1
7zfogx
10 Nov 21
Cassava Sciences Reports Third Quarter 2021 Financial Results
9:10am
8-K
EX-99.2
dkg6id1gkzlwzpm
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
go6qa12pdqwwi4kq9679
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.3
7ttyicf2
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
lhjwj
3 Aug 21
Cassava Sciences Reports Second Quarter 2021 Financial Results
8:45am
8-K
EX-99.1
66z g0dab5
21 Jun 21
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
q4mg 5qb17s
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm